Soo Jin Kim
Surgical Assistants and Surgical Technologists at Irving St, Denver, CO
License number
Colorado 1766
Issued Date
Apr 1, 2011
Renew Date
Apr 1, 2016
Expiration Date
Mar 31, 2017
Type
Surgical Technologist
Address
Address
2963 Irving St, Denver, CO 80211
Personal information
See more information about Soo Jin Kim at radaris.comName
Address
Phone
4410 Burton Way APT 1413, Colorado Spgs, CO 80918
4209 Millburn S, Colorado Spgs, CO 80906
Professional information
See more information about Soo Jin Kim at trustoria.com
Interleukin-18 Binding Proteins, Their Preparation And Use For Blocking The Activity Of Il-18
Interleukin-18 Binding Proteins, Their Preparation And Use For Blocking The Activity Of Il-18
US Patent:
6605280, Aug 12, 2003
Filed:
Oct 12, 2000
Appl. No.:
09/485632
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO
Charles Dinarello - Boulder CO
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO
Assignee:
Yeda Research and Development Company Limited - Rehovot
International Classification:
A61K 3522
US Classification:
4241841, 4241851, 4241861, 4242041, 4242321, 424 851, 530350, 530351, 530395, 530820, 530826, 530827, 530834, 514 2, 514 8, 514 9
Abstract:
Interleukin-18 binding proteins which are capable of binding IL-18 and/or modulating and/or blocking IL-18 activity are provided. Methods for their isolation and recombinant production, DNAs encoding them, DNA vectors expressing them, vectors useful for their expression in humans and other mammals, antibodies against them are also provided.
Interleukin-18 Binding Proteins, Their Preparation And Use For The Treatment Of Sepsis
Interleukin-18 Binding Proteins, Their Preparation And Use For The Treatment Of Sepsis
US Patent:
2010025, Oct 7, 2010
Filed:
Mar 1, 2010
Appl. No.:
12/715089
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Rehovot, IL
Soo Hyun Kim - Aurora CO, US
Giamila Fantuzzi - Denver CO, US
Leonid L. Reznikov - Aurora CO, US
Boris Schwartsburd - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Rehovot, IL
Soo Hyun Kim - Aurora CO, US
Giamila Fantuzzi - Denver CO, US
Leonid L. Reznikov - Aurora CO, US
Boris Schwartsburd - Rehovot, IL
Assignee:
Yeda Research Institute and Development Ltd. - Rehovot
International Classification:
A61K 38/21, A61K 39/395, A61K 38/19, A61K 35/00, A61K 31/713, A61P 31/02, A61P 9/00
US Classification:
424 854, 4241581, 514 14, 424 857, 424 856, 424 932, 514 44 R, 4241341
Abstract:
The present invention provides a method of treatment or prevention of sepsis and other diseases characteristic to the Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock, and sepsis related to cardiac dysfunction.
Methods For Treating Interleukin-18 Mediated Disorders With Interleukin-18 Binding Proteins
Methods For Treating Interleukin-18 Mediated Disorders With Interleukin-18 Binding Proteins
US Patent:
7696154, Apr 13, 2010
Filed:
Mar 15, 2007
Appl. No.:
11/724737
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Yolande Chvatchko - Confignon, CH
Christine Plater-Zyberk - Geneva, CH
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Yolande Chvatchko - Confignon, CH
Christine Plater-Zyberk - Geneva, CH
Assignee:
Yeda Research and Development Company Ltd. - Rehovot
International Classification:
A61K 38/00
US Classification:
514 2, 530350, 530351, 5303873, 435 697
Abstract:
Interleukin-18 binding proteins which are capable of binding IL-18 and of modulating and/or blocking IL-18 activity are provided. Methods for the isolation and recombinant production, DNAs encoding them. DNA vectors expressing them, vectors useful for their expression in humans and other mammals, antibodies against them are also provided. Therapeutic uses of IL-18 binding proteins and further inhibitors of IL-18 are also provided according to the invention.
Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
US Patent:
2011019, Aug 4, 2011
Filed:
Jun 11, 2009
Appl. No.:
12/482987
Inventors:
Soo Hyun Kim - Aurora CO, US
Charles A. Dinarello - Boulder CO, US
Tania Azam - Denver CO, US
Charles A. Dinarello - Boulder CO, US
Tania Azam - Denver CO, US
International Classification:
C07K 14/54
US Classification:
530351
Abstract:
The present invention relates to compositions and methods relating to an interleukin18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
Interleukin-18 Binding Proteins, Their Preparation And Use For The Treatment Of Sepsis
Interleukin-18 Binding Proteins, Their Preparation And Use For The Treatment Of Sepsis
US Patent:
7704944, Apr 27, 2010
Filed:
Aug 16, 2006
Appl. No.:
11/505554
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Giamila Fantuzzi - Chicago IL, US
Leonid L. Reznikov - Aurora CO, US
Boris Schwartsburd - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Giamila Fantuzzi - Chicago IL, US
Leonid L. Reznikov - Aurora CO, US
Boris Schwartsburd - Rehovot, IL
Assignee:
Yeda Research and Development Company Ltd. - Rehovot
International Classification:
A61K 38/00
US Classification:
514 2, 4241301, 4241341, 530350, 530351
Abstract:
The present invention provides a method of treatment or prevention of sepsis and other diseases characteristic to the Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock, and sepsis related to cardiac dysfunction.
Histone Deacetylase Enzyme-Inhibiting Derivatives Of Hydroxamic Acid As New Cytokine Synthesis-Inhibiting Anti-Inflammatory Drugs
Histone Deacetylase Enzyme-Inhibiting Derivatives Of Hydroxamic Acid As New Cytokine Synthesis-Inhibiting Anti-Inflammatory Drugs
US Patent:
2004015, Aug 12, 2004
Filed:
Apr 9, 2004
Appl. No.:
10/486152
Inventors:
Paolo Mascagni - Milano, IT
Flavio Leoni - Milano, IT
Giulia Porro - Milano, IT
Paolo Pagani - Milano, IT
Giancarlo Dona - Milano, IT
Pietro Pozzi - Milano, IT
Charles Dinarello - Milano, IT
Giamila Fantuzzi - Denver CO, US
Britta Siegmund - Milano, IT
Leonid Reznikov - Milano, IT
Philip Bufler - Milano, IT
Soo Kim - Aurora CO, US
Benjamin Pomeranz - Milano, IT
Flavio Leoni - Milano, IT
Giulia Porro - Milano, IT
Paolo Pagani - Milano, IT
Giancarlo Dona - Milano, IT
Pietro Pozzi - Milano, IT
Charles Dinarello - Milano, IT
Giamila Fantuzzi - Denver CO, US
Britta Siegmund - Milano, IT
Leonid Reznikov - Milano, IT
Philip Bufler - Milano, IT
Soo Kim - Aurora CO, US
Benjamin Pomeranz - Milano, IT
International Classification:
A61K031/19
US Classification:
514/575000
Abstract:
The use of derivatives of hydroxamic acid having histone deacetylase enzyme-inhibiting activity for the preparation of anti-inflammatory medicaments is disclosed.
Interleukin-18 Binding Proteins, Their Preparation And Use
Interleukin-18 Binding Proteins, Their Preparation And Use
US Patent:
7799541, Sep 21, 2010
Filed:
Mar 15, 2006
Appl. No.:
11/376794
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Rehovot, IL
Soo Hyun Kim - Aurora CO, US
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Rehovot, IL
Soo Hyun Kim - Aurora CO, US
Assignee:
Yeda Research and Development Company Ltd. - Rehovot
International Classification:
C12P 21/06, C12N 5/00, C12N 15/00, C07H 21/02, C07H 21/04
US Classification:
435 691, 4353201, 435325, 435455, 4352521, 435471, 536 231, 536 235
Abstract:
Interleukin-18 binding proteins which are capable of binding IL-18 and/or modulating and/or blocking IL-18 activity are provided. Methods for their isolation and recombinant production, DNAs encoding them, DNA vectors expressing them, vecotors useful for their expression in humans and other mammals, antibodies against them are also provided.
Interleukin-18 Binding Proteins, Their Preparation And Use
Interleukin-18 Binding Proteins, Their Preparation And Use
US Patent:
7220717, May 22, 2007
Filed:
Feb 21, 2001
Appl. No.:
09/790338
Inventors:
Daniela Novick - Rehovot, IL
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Yolande Chvatchko - Confignon, CH
Christine Plater-Zyberk - Geneva, CH
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Givat Shmuel, IL
Soo Hyun Kim - Denver CO, US
Yolande Chvatchko - Confignon, CH
Christine Plater-Zyberk - Geneva, CH
Assignee:
Yeda Research and Development Company Ltd. - Rehovot
International Classification:
A61K 38/00
US Classification:
514 2, 530350, 530351, 5303873, 4242801
Abstract:
Interleukin-18 binding proteins which are capable of binding IL-18 and of modulating and/or blocking IL-18 activity are provided. Methods for the isolation and recombinant production, DNAs encoding them. DNA vectors expressing them, vectors useful for their expression in humans and other mammals, antibodies against them are also provided. Therapeutic uses of IL-18 binding proteins and further inhibitors of IL-18 are also provided according to the invention.
Antibodies Against Interleukin-18 Binding Protein, Their Preparation And Use
Antibodies Against Interleukin-18 Binding Protein, Their Preparation And Use
US Patent:
8436148, May 7, 2013
Filed:
Jul 29, 2009
Appl. No.:
12/511756
Inventors:
Charles Dinarello - Boulder CO, US
Menachem Rubinstein - Rehovet, IL
Soo Hyun Kim - Aurora CO, US
Daniela Novick - Rehovot, IL
Menachem Rubinstein - Rehovet, IL
Soo Hyun Kim - Aurora CO, US
Daniela Novick - Rehovot, IL
International Classification:
C07K 16/00
US Classification:
5303881, 5303873, 530350
Abstract:
Interleukin-18 binding proteins which are capable of binding IL-18 and/or modulating and/or blocking IL-18 activity are provided. Methods for their isolation and recombinant production, DNAs encoding them, DNA vectors expressing them, vectors useful for their expression in humans and other mammals, antibodies against them are also provided.
Interleukin-18 Mutants
Interleukin-18 Mutants
US Patent:
7524488, Apr 28, 2009
Filed:
Mar 8, 2002
Appl. No.:
10/094153
Inventors:
Charles Dinarello - Boulder CO, US
Soo Hyun Kim - Denver CO, US
Soo Hyun Kim - Denver CO, US
Assignee:
Ares Trading S.A. - Aubonne
International Classification:
A61K 45/00, A61K 38/20
US Classification:
424 852, 530351
Abstract:
The invention provides mutants of IL-18 with lower affinity to IL-18BP than the wild type IL-18 molecule.
Surgical Assistants and Surgical Technologists licenses in Colorado
Merlita Samuels, Surgical Assistants and Surgical Technologists, 14330 W Warren Dr, Denver, CO 80228